Drugs / Yiqitongluo granule
last change Dec 2017 re-read 3 minutes ago

Yiqitongluo granule

Developed for
stroke disorder
Investigated by
Shineway Pharmaceutical Co.,Ltd · Yi Yang

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02604654 Dec 2015 → Nov 2017 stroke disorder Yi Yang Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Yiqitongluo granule ClinicalTrials.gov intervention name — accepted as the source's own label NCT02604654 ↗